In tandem, the company expands into Europe through partnerships with leading research and medical institutions to help them predict and prevent cancer relapse SOUTH SAN FRANCISCO, Calif. Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced the launch of Tapestri Designer, the first-ever automated, cloud-based tool for designing targeted single-cell […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation(NASDAQ:FLDM) today announced that Colin McCrackenhas joined the company as its Chief Commercial Officer. McCracken will be responsible for leading all commercial activities, driving revenue growth in new and existing markets and expanding the company’s global reach. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, […]
WATA, March 1, 2019 – Yamaha Motor Co., Ltd.(Tokyo:7272) has entered into a collaborative research project with Hubrecht Organoid Technology (HUB, the Netherlands), a leading organoid research center. Organoids are patient- derived cell cultures that mimic human organ function. The collaboration aims to accelerate technology development and jointly analyze business opportunities in this research field. Organoids […]
To radically simplify processes and increase productivity for researchers, RoosterBio Inc. has launched two bioprocess media products, RoosterCollect™-EV and EV Boost™, that supplement a scalable xeno-free manufacturing… Dependable EV or exosome collection that is tunable to workflows will accelerate product development. FREDERICK, Md. — To radically simplify processes and increase productivity for researchers, RoosterBio Inc. has […]
Series B financing will drive expansion of commercial operations and development of new microOrgan® platforms MAPLE GROVE, MN – StemoniX® Inc., a biotech company revolutionizing how new medicines are discovered, announced today that it has secured $14.4 million USD in Series B funding from a group of institutional and private investors. Brightstone Venture Capital led the financing and […]
German scientist will employ xCELLigence Real Time Cell Analysis (RTCA) technology to develop an oncolytic virus and use T cell receptor (TCR) transgenic T cells to deliver the virus to specific tumors. SAN DIEGO Teresa Krabbe, Ph.D., a student in the working group of Dr. Jennifer Altomonte at Klinikum Rechts der Isar of the Technical […]
$10 Million Army Research Contract Advances Precision Biodesign PALO ALTO, Calif.— Cells form the cornerstone of life, and Lockheed Martin (NYSE: LMT) is researching ways to create the building blocks of novel materials. In a new cooperative agreement with the Army Research Laboratory, Lockheed Martin material scientists will work with industry and Army scientists who […]
Winnipeg, MB – Cubresa Inc., a world leader in PET inserts for MRI, has selected a Chinese distributor for its NuPET™ preclinical imaging product line. Cubresa is pleased to announce that it has signed an agreement with Worldwide Technology (S.H.) Co., Ltd. (WAD), a Shanghai-based distributor who specializes in the sale of life sciences related equipment […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive agreement with General Electric Company (“GE”) (NYSE: GE) to acquire the Biopharma business of GE Life Sciences (“GE Biopharma”) for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net […]
Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s innovative image-driven liquid handling […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
